The United States Pharmacopeia report reveals the highest drug shortages in a decade, with over 125 monitored by the FDA in 2023, impacting a variety of drugs for prolonged periods.
Market vulnerabilities contribute to over a quarter of new drug shortages, lasting more than three years on average, with injectable generic medications making up the majority, creating risks for patient access.
[
Collection
]
[
|
...
]